GlobeNewswire: Proxy Statements And Analysis Contains the last 10 releaseshttp://globenewswire.com/External?Length=42017-08-18T05:02:21ZGlobeNewswirehttp://globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)http://globenewswire.com/news-release/2017/07/24/1056094/0/en/Leading-Advisory-Firms-ISS-and-Glass-Lewis-Support-Plan-of-Arrangement-Between-NOVADAQ-Technologies-Inc-and-Stryker-Corporation.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisLeading Advisory Firms ISS and Glass Lewis Support Plan of Arrangement Between NOVADAQ Technologies Inc. and Stryker Corporation2017-07-24T12:00:00Z<![CDATA[TORONTO, July 24, 2017 (GLOBE NEWSWIRE) -- NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”), is pleased to announce that both Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that shareholders of NOVADAQ vote FOR the resolution to approve the plan of arrangement (the “Arrangement”) pursuant to which Stryker Corporation has agreed to acquire all of the issued and outstanding shares of NOVADAQ for US$11.75 per share in cash.]]>http://globenewswire.com/news-release/2017/05/31/1004779/0/en/Chevron-shareholders-vote-on-doing-business-with-genocide-complicit-governments.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisChevron shareholders vote on doing business with genocide-complicit governments2017-05-31T18:22:12Z<![CDATA[Vote on Burmese Rohingya resolution exceeds threshold needed to resubmit proposal next year]]>http://globenewswire.com/news-release/2017/05/22/994627/0/en/Rockwell-Medical-Issues-Letter-to-Shareholders-Explaining-Why-Electing-Mark-Ravich-Could-Do-Lasting-Harm.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisRockwell Medical Issues Letter to Shareholders Explaining Why Electing Mark Ravich Could Do Lasting Harm2017-05-22T12:20:12Z<![CDATA[Urges Shareholders to Vote “FOR” David Domzalski on the WHITE Proxy Card]]>http://globenewswire.com/news-release/2017/05/12/984559/0/en/Innocoll-Announces-Proxy-Statement-Mail-Out-to-Shareholders.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisInnocoll Announces Proxy Statement Mail-Out to Shareholders2017-05-12T21:35:15Z<![CDATA[NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.]]>http://globenewswire.com/news-release/2017/04/21/963732/0/en/Rockwell-Medical-Files-Definitive-Proxy-Materials.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisRockwell Medical Files Definitive Proxy Materials2017-04-21T12:30:00Z<![CDATA[]]>http://globenewswire.com/news-release/2017/04/20/963470/0/en/Shareholder-Challenges-the-Increase-in-Authorized-Shares.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisShareholder Challenges the Increase in Authorized Shares2017-04-20T20:39:15Z<![CDATA[WESTERN SPRINGS, Ill., April 20, 2017 (GLOBE NEWSWIRE) -- Shareholder Philip J. Timyan, an investor in Community West Bancshares (NASDAQ:CWBC), sent a letter on April 19, 2017 to Chairman William R. Peeples reporting that he did not believe a 200% increase in authorized shares was a good idea. The letter that Philip Timyan sent to Chairman Peeples follows.]]>http://globenewswire.com/news-release/2017/04/12/959640/10166389/en/Equilar-100-CEO-Pay-Increases-6-Reaches-15-million-for-Largest-U-S-Companies.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisEquilar 100: CEO Pay Increases 6%, Reaches $15 million for Largest U.S. Companies2017-04-12T14:09:45Z<![CDATA[REDWOOD CITY, Calif., April 12, 2017 (GLOBE NEWSWIRE) -- After seeing more modest gains than previous years in 2015, CEO pay appears to be trending upwards yet again. Among CEOs in the ]]>http://globenewswire.com/news-release/2017/04/11/958767/0/en/LPL-Financial-Files-Definitive-Proxy-Materials-Announces-Nomination-of-William-Glavin-as-New-Independent-Director.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisLPL Financial Files Definitive Proxy Materials, Announces Nomination of William Glavin as New Independent Director2017-04-11T12:30:22Z<![CDATA[Current Director John Brennan will not seek reelection to the Board]]>http://globenewswire.com/news-release/2017/02/15/917769/0/en/Immunomedics-Sends-Letter-to-Stockholders-Highlighting-Value-Creating-Global-Licensing-Agreement-Underscoring-Fulfillment-of-Promise-to-Stockholders.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisImmunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders2017-02-15T21:15:00Z<![CDATA[]]>http://globenewswire.com/news-release/2016/12/29/902190/0/en/Sevcon-Responds-to-Dissident-Board-Member-s-Shareholder-Proposals-as-to-Board-Composition.html?f=22&fvtc=1&fvtv=Proxy%20Statements%20And%20AnalysisSevcon Responds to Dissident Board Member’s Shareholder Proposals as to Board Composition2016-12-29T16:36:07Z<![CDATA[SOUTHBOROUGH, Mass., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Sevcon, Inc. (Nasdaq:SEV) (“Sevcon” or the “Company”) today sets the record straight for its stockholders, customers, suppliers, employees and other constituents about the significant actions your Board of Directors and management team have undertaken to best position the Company for future growth and maximize shareholder value. This communication is occasioned by the Company’s need to respond to a proposal by a dissident director and former Executive Chairman who, along with the activist hedge fund that he operates, Meson Capital LP (“Meson”), seeks to nominate a slate of directors at the 2017 Annual Meeting of Stockholders.]]>